The U.S. Food and Drug Administration (FDA) released a statement on Monday (1/4) urging healthcare providers to follow the approved dosing schedules for COVID-19 vaccinations, after discussions of changing doses, limiting doses, and extending length of time in between doses. The FDA warns that without proper data supporting these changes, the health of the public could be jeopardized as the 94-95% efficacy rate is specific to following the vaccination dosing schedules.
Read more here.
More on: News Regulatory